95.23 - 97.14
55.47 - 103.81
1.63M / 1.81M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.88%
Revenue growth under 50% of NEM's 13.02%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
9.53%
Gross profit growth under 50% of NEM's 31.18%. Michael Burry would be concerned about a severe competitive disadvantage.
8.65%
EBIT growth below 50% of NEM's 33.92%. Michael Burry would suspect deeper competitive or cost structure issues.
8.65%
Operating income growth under 50% of NEM's 33.92%. Michael Burry would be concerned about deeper cost or sales issues.
10.43%
Net income growth under 50% of NEM's 272.34%. Michael Burry would suspect the firm is falling well behind a key competitor.
7.14%
EPS growth under 50% of NEM's 266.67%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
7.14%
Diluted EPS growth under 50% of NEM's 266.67%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.07%
Share reduction more than 1.5x NEM's 0.19%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.09%
Diluted share reduction more than 1.5x NEM's 0.38%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
3.97%
OCF growth under 50% of NEM's 41.02%. Michael Burry might suspect questionable revenue recognition or rising costs.
4.72%
FCF growth under 50% of NEM's 77.72%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
141.61%
10Y revenue/share CAGR above 1.5x NEM's 21.85%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
-20.62%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
8.81%
Positive 3Y CAGR while NEM is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
124.63%
10Y OCF/share CAGR at 50-75% of NEM's 171.67%. Martin Whitman might fear a structural deficiency in operational efficiency.
-42.27%
Negative 5Y OCF/share CAGR while NEM is at 41.06%. Joel Greenblatt would question the firm’s operational model or cost structure.
-1.57%
Negative 3Y OCF/share CAGR while NEM stands at 31.32%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
48.42%
Below 50% of NEM's 107.18%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-61.72%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-13.79%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
238.97%
10Y equity/share CAGR above 1.5x NEM's 26.63%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
41.60%
Positive 5Y equity/share CAGR while NEM is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
16.36%
Positive short-term equity growth while NEM is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
-34.46%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
-5.82%
Negative near-term dividend growth while NEM invests at 110.65%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
13.77%
AR growth well above NEM's 18.25%. Michael Burry fears inflated revenue or higher default risk in the near future.
No Data
No Data available this quarter, please select a different quarter.
-1.47%
Negative asset growth while NEM invests at 0.83%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
1.03%
1.25-1.5x NEM's 0.85%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
-10.43%
We’re deleveraging while NEM stands at 0.04%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
15.14%
SG&A growth well above NEM's 5.45%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.